Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 1:7:2049936120941725.
doi: 10.1177/2049936120941725. eCollection 2020 Jan-Dec.

Vector-borne diseases in pregnancy

Affiliations
Review

Vector-borne diseases in pregnancy

Brendan O'Kelly et al. Ther Adv Infect Dis. .

Abstract

Vector-borne infections cause a significant proportion of world-wide morbidity and mortality and many are increasing in incidence. This is due to a combination of factors, primarily environmental change, encroachment of human habitats from urban to peri-urban areas and rural to previously uninhabited areas, persistence of poverty, malnutrition and resource limitation in geographical areas where these diseases are endemic. Pregnant women represent the single largest 'at risk' group, due to immune-modulation and a unique physiological state. Many of these diseases have not benefitted from the same level of drug development as other infectious and medical domains, a factor attributing to the 'neglected tropical disease' title many vector-borne diseases hold. Pregnancy compounds this issue as data for safety and efficacy for many drugs is practically non-existent, precluding exposure in pregnancy to many first-line therapeutic agents for 'fear of the unknown' or overstated adverse pregnancy-foetal outcomes. In this review, major vector-borne diseases, their impact on pregnancy outcomes, current treatment, vaccination and short-comings of current medical practice for pregnant women will be discussed.

Keywords: neglected tropical diseases; pregnancy; vector-borne diseases.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Similar articles

  • Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J, Casey CG, Bell DM; Centers for Disease Control and Prevention. Cono J, et al. MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28. MMWR Recomm Rep. 2003. PMID: 12617510
  • Tick-borne relapsing fever and pregnancy outcome in rural Tanzania.
    Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. Jongen VH, et al. Acta Obstet Gynecol Scand. 1997 Oct;76(9):834-8. doi: 10.3109/00016349709024361. Acta Obstet Gynecol Scand. 1997. PMID: 9351408
  • The antipoverty vaccines.
    Hotez PJ, Ferris MT. Hotez PJ, et al. Vaccine. 2006 Jul 26;24(31-32):5787-99. doi: 10.1016/j.vaccine.2006.05.008. Epub 2006 May 17. Vaccine. 2006. PMID: 16759763 Review.
  • Emerging Vector-Borne Diseases - Incidence through Vectors.
    Savić S, Vidić B, Grgić Z, Potkonjak A, Spasojevic L. Savić S, et al. Front Public Health. 2014 Dec 2;2:267. doi: 10.3389/fpubh.2014.00267. eCollection 2014. Front Public Health. 2014. PMID: 25520951 Free PMC article.
  • Tuberculosis.
    Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.

Cited by

References

    1. World Health Organization. A global brief on vector-borne diseases, https://apps.who.int/iris/bitstream/handle/10665/111008/WHO_DCO_WHD_2014... (2014). (accessed 12 June 2020).
    1. World Health Organization. Global vector control response 2017–2030. Geneva: World Health Organization, 2014.
    1. Franklinos LHV, Jones KE, Redding DW, et al. The effect of global change on mosquito-borne disease. Lancet Infect Dis 2019; 19: e302–e312. - PubMed
    1. Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am 2015; 29: 187–210. - PubMed
    1. Vandekerckhove O, De Buck E, Van Wijngaerden E. Lyme disease in Western Europe: an emerging problem? A systematic review. Acta Clin Belg. Epub ahead of print 18 November 2019. DOI: 10.1080/17843286.2019.1694293. - DOI - PubMed

LinkOut - more resources